- Telehealth Visits
- Insurance plan information
Blair Anderson, NP, MSN
She | Her | HersMedical Oncology • Blood and Marrow Transplant- Telehealth Visits
- Insurance plan information
Blair Anderson, NP, MSN
She | Her | HersMedical Oncology • Blood and Marrow Transplant- Telehealth Visits
- Insurance plan information
On this page
About me
Blair Anderson is a nurse practitioner who provides care in the hospital for patients undergoing chemotherapy, immunotherapy or stem cell transplantation to treat blood cancer.
Anderson earned a bachelor's degree in nursing from Duquesne University. She earned her master's degree in nursing at the University of Cincinnati.
Education & training
Board certification
- Family Nurse Practitioner, American Academy of Nurse Practitioners
Degree
- MSN, University of Cincinnati
My expertise
Specialties
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%224128%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224128%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.